SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Panderzheng reduced its holdings of PRECIOUS DRAGON (01861) by 56,000 shares, with a price of 2.4214 Hong Kong dollars per share.
Chen Chongyi increased his holding of HKC INT'L HOLD (00248) by 500,000 shares at a price of HKD 0.25 per share.
FUFENG GROUP (00546) spent HKD 483,000 to repurchase 100,000 shares on July 9th.
Panderzheng reduced its holdings of PRECIOUS DRAGON (01861) by 56,000 shares, with a price of 2.4214 Hong Kong dollars per share.
Chen Chongyi increased his holding of HKC INT'L HOLD (00248) by 500,000 shares at a price of HKD 0.25 per share.
FUFENG GROUP (00546) spent HKD 483,000 to repurchase 100,000 shares on July 9th.
RECOMMEND
